Bank Of New York Mellon Corp Horizon Therapeutics Public LTD CO Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$107.32 - $113.5 $228 Million - $241 Million	2,126,573 New	2,126,573 $232 Billion
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $174 Million - $318 Million	2,795,753 New	2,795,753 $318 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $346,331 - $497,690	-5,878 Reduced 0.16%	3,751,564 $232 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $13.6 Million - $20 Million	-171,500 Reduced 4.37%	3,757,442 $300 Million
Q1 2022 May 11, 2022	BUY	$86.42 - $109.81 $24.5 Million - $31.1 Million	283,198 Added 7.77%	3,928,942 $413 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $13.6 Million - $16.5 Million	-137,507 Reduced 3.63%	3,645,744 $393 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $7.13 Million - $8.57 Million	-77,626 Reduced 2.01%	3,783,251 $414 Million
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $6.11 Million - $6.8 Million	-70,864 Reduced 1.8%	3,860,877 $362 Million
Q1 2021 Oct 08, 2021	BUY	$71.83 - $95.48 $282 Million - $375 Million	3,931,741 New	3,931,741 $362 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $253 Million - $336 Million	-3,516,538 Closed	0 $0
Q4 2020 Oct 08, 2021	BUY	$67.0 - $84.39 $236 Million - $297 Million	3,516,538 New	3,516,538 $257 Million
Q4 2020 Feb 09, 2021	SELL	$67.0 - $84.39 $183 Million - $230 Million	-2,731,048 Closed	0 $0
Q3 2020 Oct 08, 2021	BUY	$55.23 - $79.93 $151 Million - $218 Million	2,731,048 New	2,731,048 $212 Million
Q3 2020 Nov 12, 2020	SELL	$55.23 - $79.93 $127 Million - $184 Million	-2,297,617 Closed	0 $0
Q2 2020 Oct 08, 2021	BUY	$30.2 - $56.98 $69.4 Million - $131 Million	2,297,617 New	2,297,617 $128 Million
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $23.1 Million - $43.6 Million	-764,345 Closed	0 $0
Q1 2020 Oct 08, 2021	BUY	$24.87 - $38.56 $19 Million - $29.5 Million	764,345 New	764,345 $22.6 Million
Q1 2020 May 06, 2020	SELL	$24.87 - $38.56 $19.3 Million - $29.9 Million	-774,326 Closed	0 $0
Q4 2019 Oct 08, 2021	BUY	$25.43 - $36.67 $19.7 Million - $28.4 Million	774,326 New	774,326 $28 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $22.2 Million - $32 Million	-873,732 Closed	0 $0
Q3 2019 Oct 08, 2021	BUY	$23.0 - $27.97 $20.1 Million - $24.4 Million	873,732 New	873,732 $23.8 Million
Q3 2019 Nov 07, 2019	SELL	$23.0 - $27.97 $18.5 Million - $22.5 Million	-802,881 Closed	0 $0
Q2 2019 Oct 08, 2021	BUY	$22.81 - $28.48 $18.3 Million - $22.9 Million	802,881 New	802,881 $19.3 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account